Comment on: Protective role of recombinant human erythropoietin in kidney and lung injury following renal bilateral ischemia-reperfusion in rat model

International Journal of Preventive Medicine

Volumn 4, Issue 10, 2013, Pages 1226-1228

  Ardalan, Mohammad Reza ^a   Nasri, Hamid ^b   Rafieian Kopaei, Mahmoud ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GENTAMICIN; NITRITE; NITROGEN; RECOMBINANT ERYTHROPOIETIN; UREA;

ADVERSE OUTCOME; CREATININE BLOOD LEVEL; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ERYTHROPOIESIS; KIDNEY INJURY; KIDNEY ISCHEMIA; LETTER; LUNG INJURY; MEMBRANE PERMEABILITY; NONHUMAN; PREVENTIVE MEDICINE; RAT; RENAL PROTECTION; REPERFUSION INJURY; UREA NITROGEN BLOOD LEVEL;

EID: 84885466411     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Letter

References (18)

1. Moeini M, Nematbakhsh M, Fazilati M, Talebi A, Pilehvarian AA, Azarkish F, et al. Protective role of recombinant human erythropoietin in kidney and lung injury following renal bilateral ischemia-reperfusion in rat model. Int J Prev Med 2013;4:648-55.
2. Rafieian-Kopaei M, Nasri H, Nematbakhsh M, Baradaran A, Gheissari A, Rouhi H, et al. Erythropoietin ameliorates gentamicin: Induced renal toxicity: A biochemical and histopathological study. J Nephropathology 2012;1:109-16.
3. Tavafi M. Protection of renal tubules against gentamicin induced nephrotoxicity. J Ren Inj Prev 2012;2:5-6.
4. Kadkhodaee M. Erythropoietin; bright future and new hopes for an old drug. J Nephropathology 2012;1:81-2.
5. Nasri H, Madihi Y, Marikhi A. Commentary on: Effects of cinnamon consumption on glycemic status, lipid profile and body composition in type 2 diabetic patients. Int J Prev Med 2013;4:618-9.
6. Sanadgol H, Abdani S, Tabatabaiee P, Mohammadi M. Protective effect of high dose short term statin therapy with normal saline in prevention of contrast-induced nephropathy among iodixanol-receiving patients. J Ren Inj Prev 2013;1:43-5.
7. Gheissari A. Acute kidney injury and renal angina. J Ren Inj Prev 2013;2:33-4.
8. Nasri H, Nematbakhsh M, Ghobadi S, Ansari R, Shahinfard N, Rafieian-Kopaei M. Preventive and curative effects of ginger extract against histopathologic changes of gentamicin-induced tubular toxicity in rats. Int J Prev Med 2013;4:316-21.
9. Nasri H. Acute kidney injury and beyond. J Ren Inj Prev 2012;1:1-2.
10. Tavafi M. Inhibition of gentamicin: Induced renal tubular cell necrosis. J Nephropathology 2012;1:83-6.
11. Baradaran A, Nasri H. Re: Effect of erythropoietin on kidney allograft survival: Early use after transplantation. Iran J Kidney Dis 2013;7:332-3.
12. Nasri H, Ghorbani A. Does erythropoietin slow progression of chronic kidney disease? J Ren Inj Prev 2013;2:81-2.
13. Gobe GC, Morais C, Vesey DA, Johnson DW. Use of high-dose erythropoietin for repair after injury: A comparison of outcomes in heart and kidney. J Nephropathology 2013;2:154-65.
14. Rafieian-Kopaie M, Nasri H. R: Recombinant human erythropoietin reduces rhabdomyolysis-induced acute renal failure in rats. Injury 2013. [E-pub ahead of print].
15. Fliser D, Bahlmann FH, Haller H. EPO: Renoprotection beyond anemia correction. Pediatr Nephrol 2006;21:1785-9.
16. Nasri H, Rafieian-Kopaei M. Preventive role of erythropoietin against aminoglycoside renal toxicity induced nephropathy; current knowledge and new concepts. J Ren Inj Prev 2013;2:29-30.
17. Abe T, Isaka Y, Imamura R, Kakuta Y, Okumi M, Yazawa K, et al. Carbamylated erythropoietin ameliorates cyclosporine nephropathy without stimulating erythropoiesis. Cell Transplant 2012;21:571-80.
18. Rafieian-Kopaei M, Nasri H. Comment on: Is the renoprotective effect of erythropoietin in chronic kidney disease a myth? J Formos Med Assoc 2013.